StockWatch
·
Q2 FY-2027 RESULTS · M&MFIN

Mahindra Finance: Consolidated PAT Jumps 61% YoY to ₹911 Cr, NPM Expands to 15.3%

PAT +60.89% YoY · revenue +18.09% · margins expanding · inline vs street

Q2 FY27 resultsM&MFINMAHINDRA & MAHINDRA FINANCIAL SERVICES LTD.21 Oct 2026 · 3 min read
Revenue

₹5,935.66 Cr

+18.09% YoY

PAT (consolidated)

₹910.73 Cr

+60.89% YoY

Net margin

15.28%

+4.1pp YoY

EPS

₹6.54

Mahindra & Mahindra Financial Services posted consolidated PAT of ₹910.73 Cr for Q2 FY27, up 60.9% YoY from ₹566.07 Cr a year ago, on consolidated revenue from operations of ₹5,935.66 Cr, up 18.1% YoY from ₹5,026.19 Cr. Standalone PAT came in at ₹881.52 Cr (EPS ₹6.34) against consolidated EPS of ₹6.54; YoY profit growth was somewhat stronger at the consolidated level (+60.9%) than standalone (+54.8%), a gap consistent with scale-up at housing-finance subsidiary MRHFL ahead of its planned April 2027 merger into the parent. Sequentially, PAT eased 1.8% QoQ from Q1 FY27's ₹927.48 Cr even as revenue grew 3.8% QoQ — a mild step-down after Q1's exceptional 75% YoY profit jump, which the pre-result preview had flagged as a tough comparison to sustain. This quarter's slower-but-still-strong 61% YoY print reads as normalization rather than deterioration, with NPM still expanding to 15.28% from 11.21% a year ago (versus 16.20% in Q1, so a touch of sequential margin give-back).

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹5,935.66 Cr+3.8%+18.1%
Expenses₹4,760.55 Cr+5.7%+10.6%
PAT₹910.73 Cr-1.81%+60.89%
Net margin15.28%-0.9pp+4.1pp
EPS₹6.54-1.8%+61.1%

The YoY margin expansion was driven by a lower provisioning load relative to book growth: half-year impairment on financial instruments came in at ₹1,195.82 Cr, which annualizes to roughly 1.6% of the average loan book (₹1,46,017.84 Cr) — comfortably within management's guided 1.3-1.7% through-cycle credit-cost band. Finance costs rose to ₹2,523.00 Cr for the quarter from ₹2,197.68 Cr a year ago as the balance sheet grew (total assets to ₹1,80,291.69 Cr from ₹1,58,643.94 Cr at FY26-end), but revenue growth outpaced the rise in cost of funds, letting operating leverage flow through. No exceptional items hit either the current or year-ago quarter, so the 60.9% YoY PAT growth is a clean, unadjusted figure.

₹
283.67319.27354.88390.48426.08297.4507-2008-1109-0209-2510-21Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹297.45, down 15.8% over the past month of trading.

₹ Cr
0351.11702.231,053.34528.96Q1 FY26rev ₹4,991 Cr566.07Q2 FY26rev ₹5,026 Cr810.44Q3 FY26rev ₹4,754 Cr940.48Q4 FY26rev ₹5,539 Cr927.48Q1 FY27rev ₹5,718 Cr910.73Q2 FY27rev ₹5,936 Cr
Quarterly consolidated PAT, ₹ Crore

For context: revenue is at a 6-quarter high.

Beyond the headline

What the summary numbers don't show

Capital Adequacy Ratio 17.98% (standalone), Debt/Equity 5.49x

What management guided (1 FY-2027 call)
FY26-31 CAGR 16-18% (wheels 11-12%, non-wheels 30%+); credit cost 1.3-1.7% through-cycle; ROA progressing to 2.5% target; no capex needed for 6-8 quarters.

— This quarter: met

Against our pre-result preview (PAT ~₹850-950 Cr, revenue ~₹5,700-5,900 Cr), the print landed inline — PAT at ₹910.73 Cr sat mid-band and revenue at ₹5,935.66 Cr came in marginally above the top of the guided range. No independent brokerage consensus PAT estimate turned up in search beyond the preview itself; Street positioning (60.6% Buy rating, ₹350 median target versus a pre-result price of ₹319.45) centered on execution risk around the MRHFL merger and sustaining 20%+ disbursement growth — both of which this quarter's 22% YoY disbursement growth (to ₹16,490 Cr, per the company's October 2 business update) and the board's merger clearance help address. Standalone gross Stage-3 came in at 3.42% (net 1.51%, PCR 56.64%), within the pre-flagged 3.35-3.45% range, confirming asset quality held up as expected; collection efficiency wasn't separately disclosed in this filing, so the previewed 97% figure couldn't be independently verified. The quarter also saw ₹2,000 Cr and ₹1,250 Cr NCD raises (the latter at a 7.95% fixed coupon) and a steady-to-improved ESG rating, neither of which shows up directly in this quarter's P&L. No standalone press release commentary was available to extract management's own framing of the quarter.

  • W1

    PAT growth normalization — 61% YoY this quarter vs Q1's 75% YoY; watch convergence toward the ~22% disbursement growth rate as the high base laps in H2 FY27

  • W2

    Credit cost — ~1.6% annualized (HY basis) within the guided 1.3-1.7% through-cycle band; watch for drift toward the top as the book scales

  • W3

    MRHFL merger integration ahead of the April 1, 2027 appointed date, and its effect on costs/ROA progress toward the 2.5% target

Clean digital filing; both statements reconcile exactly (totalIncome=revenue+other income; PBT-tax=PAT to the rupee). Consolidated PBT bridges via ₹21.79 Cr share of associate/JV profit (Mahindra Finance USA, Manulife JVs); no exceptional items in Q2 FY27 or Q2 FY26 (FY26 full-year exceptional of ₹132.95 Cr consol/₹117.33 Cr standalone, from New Labour Codes provisioning, sits outside both compared quarters). NCI of ₹1.30 Cr this quarter excluded from headline consolidated PAT per standard convention.

Informational and educational content only. Not investment advice.